Glenn Goddard, EVP, Chief Financial Officer at Intellia Therapeutics, Inc. (NTLA), sold 40,000 shares at $150.65 ($6.0M) on 2021-08-05, disclosed to the SEC on 2021-08-06.
Open-market sale of $6.0M NTLA by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.65 | 9,902 | $1.5M | 24.7% |
| 2 | $150.65 | 9,902 | $1.5M | 24.7% |
| 3 | $151.41 | 9,568 | $1.4M | 24.0% |
| 4 | $151.41 | 9,568 | $1.4M | 24.0% |
| 5 | $152.13 | 530 | $81K | 1.3% |
| 6 | $152.13 | 530 |
| $81K |
| 1.3% |
| Total | $151.05 avg | 40,000 | $6.0M | 100% |
| Filing → |
| NTLA | SELL | 2022-03-03 | $227K | — | Filing → |
| NTLA | SELL | 2021-09-09 | $1.3M | — | Filing → |
| NTLA | SELL | 2021-09-01 | $5.0M | — | Filing → |